MET and non-small cell lung carcinoma: Aberrant activation of the c-Met axis due to genomic amplification, mutation, overexpression, or alternative splicing sustains a pro-oncogenic phenotype in various solid tumors, such as NSCLC, gastrointestinal, and hepatocellular carcinomas.